Annual Accounts Receivable
$2.77 M
-$495.00 K-15.18%
December 31, 2023
Summary
- As of March 11, 2025, CARA annual accounts receivable is $2.77 million, with the most recent change of -$495.00 thousand (-15.18%) on December 31, 2023.
- CARA annual accounts receivable is now -15.18% below its all-time high of $3.26 million, reached on December 31, 2022.
Performance
CARA Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$435.00 K
+$76.00 K+21.17%
September 30, 2024
Summary
- As of March 11, 2025, CARA quarterly accounts receivable is $435.00 thousand, with the most recent change of +$76.00 thousand (+21.17%) on September 30, 2024.
- Over the past year, CARA quarterly accounts receivable has stayed the same.
- CARA quarterly accounts receivable is now -95.70% below its all-time high of $10.12 million, reached on June 30, 2023.
Performance
CARA Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CARA Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.2% | 0.0% |
| 3 y3 years | - | 0.0% |
| 5 y5 years | - | 0.0% |
CARA Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.2% | -100.0% | -95.7% | -100.0% |
| 5 y | 5-year | -15.2% | -100.0% | -95.7% | -100.0% |
| alltime | all time | -15.2% | -100.0% | -95.7% | -100.0% |
Cara Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $435.00 K(+21.2%) |
| Jun 2024 | - | $359.00 K(-79.1%) |
| Mar 2024 | - | $1.72 M(-37.9%) |
| Dec 2023 | $2.77 M | $2.77 M(-17.5%) |
| Sep 2023 | - | $3.35 M(-66.9%) |
| Jun 2023 | - | $10.12 M(+66.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $6.07 M(+86.1%) |
| Dec 2022 | $3.26 M(>+9900.0%) | $3.26 M(-66.1%) |
| Sep 2022 | - | $9.62 M(+20.2%) |
| Jun 2022 | - | $8.00 M(+220.6%) |
| Mar 2022 | - | $2.50 M(>+9900.0%) |
| Dec 2021 | $0.00 | $0.00 |
FAQ
- What is Cara Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Cara Therapeutics?
- What is Cara Therapeutics annual accounts receivable year-on-year change?
- What is Cara Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Cara Therapeutics?
- What is Cara Therapeutics quarterly accounts receivable year-on-year change?
What is Cara Therapeutics annual accounts receivable?
The current annual accounts receivable of CARA is $2.77 M
What is the all time high annual accounts receivable for Cara Therapeutics?
Cara Therapeutics all-time high annual accounts receivable is $3.26 M
What is Cara Therapeutics annual accounts receivable year-on-year change?
Over the past year, CARA annual accounts receivable has changed by -$495.00 K (-15.18%)
What is Cara Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of CARA is $435.00 K
What is the all time high quarterly accounts receivable for Cara Therapeutics?
Cara Therapeutics all-time high quarterly accounts receivable is $10.12 M
What is Cara Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, CARA quarterly accounts receivable has changed by $0.00 (0.00%)